Tenet Healthcare Corporation (THC)
BiotechSign Signal Grade
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Pipeline Overview
- Therapeutic Focus
- Biotech / Pharmasrc
Clinical Trial Activity
(ClinicalTrials.gov aggregate)
ClinicalTrials.gov aggregate as of 2026-10-06. ClinicalTrials.gov
Dilution Risk
LOW DILUTION RISKDilution score: 9/100 (LOW), cash runway not available
Derived from verified regulatory filings. Measures dilution exposure from warrants, convertibles, and offering history. DilutionWatch SEC-derived score
Short Interest
Short interest: 2.37% of float, squeeze risk: LOW
FINRA short sale data. FINRA short interest
Recent News & SEC Filings
- Tenet Upgrades Full Year 2026 Revenue Guidance Following Latest Operating Results and Developments
- Tenet Healthcare (THC) Outpaces Stock Market Gains: What You Should Know
- Tenet to Report Its Third Quarter 2026 Results on October 29
- Tenet Healthcare (THC): Buy, Sell, or Hold Post Q2 Earnings?
- Tenet Adds First U.S. Exclusive Commercial Lender to Business Hub and Welcomes New West Coast Business Development Manager
- Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?
- Is Tenet Healthcare Corporation (THC) A Solid Play on Expanding Ambulatory Business?
- Tenet Healthcare (THC) Faces A Fresh Valuation Test After Its Debt Refinance
Headlines from public sources. BiotechSign does not endorse or verify linked content.
Recent Publications
- Co-treatment with Gabapentinoid and Japanese Herbal Medicine Goshajinkigan for CIPN is Associated with Longer Duration and Higher Dose of Chemotherapy. — Adv Ther 2025 Jun PMID 40252163
- Effects of M-DEPTH model of depression care on maternal depression, functioning, and HIV care adherence, and infant developmental over eighteen months post-partum: results from a cluster randomized controlled trial. — BMC Pregnancy Childbirth 2025 Apr 5 PMID 40188047
- Parenteral prostacyclin utilization in patients with pulmonary arterial hypertension in the intermediate-risk strata: a retrospective chart review and cross-sectional survey. — BMC Pulm Med 2024 Nov 20 PMID 39567921
- Assessing Computational Model Credibility Using a Risk-Based Framework: Application to Hemolysis in Centrifugal Blood Pumps. — ASAIO J 2019 May/Jun PMID 30973403
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for Tenet Healthcare Corporation.
Full THC Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.